# US 2017/0283456 A1 · Protein labeling with cyanobenzothiazole conjugates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0283456 A1
- Document ID: US20170283456A1
- Status: Published application
- Kind: A1
- Application number: 15/623,663
- Filed: 2017-06-15
- Published: 2017-10-05
- Earliest claimed: 2008-03-27
- Assignees: Promega Corporation
- Applicants: Promega Corporation
- Inventors: Jessica Kelts; Poncho Meisenheimer; John Shultz
- Web page: https://patentgrep.com/patent/US20170283456A1

## CPC

- C07K 1/13: Labelling of peptides
- C07D 417/14: containing three or more hetero rings
- C07D 493/10: Spiro-condensed systems
- C07D 495/04: Ortho-condensed systems
- C09B 11/08: Phthaleins; {Phenolphthaleins; Fluorescein}
- C09B 11/24: Phthaleins containing amino groups {; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes}
- C09B 23/083: {five >CH- groups}
- G01N 33/52: Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)}
- G01N 33/533: with fluorescent label
- G01N 33/6845: {Methods of identifying protein-protein interactions in protein mixtures}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention provides compounds and methods for site-specifically labeling proteins with cyanobenzothiazole derivatives of formula I. For example, the invention provides methods for labeling the N-terminus of a protein that terminates with a cysteine residue. The invention also provides methods for isolating an N-terminally labeled protein and methods for detecting an N-terminally labeled protein.

## Claims

### Claim 1

A method for labeling a peptide or protein, comprising:
contacting a sample comprising an N-terminal cysteine labeled peptide or protein with a cyanobenzothiazole derivative of Formula I
wherein
Z is H, F, Cl, Br, I, CN, amino, alkylamino, dialkylamino, alkyl ester, carboxy, carboxylic acid salt, alkyl amide, phosphate, alkyl phosphonate, sulfate, alkyl sulfonate, nitro, or C1-C10 alkyl; wherein Z may be optionally unsaturated and optionally substituted with amino, hydroxy, oxo (═O), nitro, thiol, or halo;
each R1 is independently H, F, Cl, Br, I, CN, C1-C6 alkyl, C1-C6 alkoxy, or C1-C6 alkylthio, wherein each alkyl, alkoxy, or alkylthio is optionally substituted with F, Cl, Br, I, amino, alkenyl, alkynyl, cycloalkyl, aryl,alkyl sulfonate, or CO2M wherein M is H, an organic cation, or an inorganic cation;
n is 0, 1, or 2;
Y is absent or is a linking group comprising C1-C16 alkyl optionally substituted with one or more halo, oxo (═O), C1-C6alkyl, or C1-C6alkoxy, and optionally interrupted with one or more N(R1), O, S, or —NH—C(═O)— groups; and
X is a fluorescent dye;
so as to yield a fluorescently-labeled peptide or protein.

### Claim 2 (depends on 1)

The method of claim 1, further comprising detecting the fluorescently-labeled peptide or protein.

### Claim 3 (depends on 1)

The method of claim 1, wherein the sample comprises a cell-free translation system.

### Claim 4 (depends on 1)

The method of claim 1, wherein the sample comprises intact eukaryotic cells.

### Claim 5 (depends on 1)

The method of claim 1, wherein the peptide is synthetically derived.

### Claim 6 (depends on 1)

The method of claim 1, further comprising:
combining the fluorescently-labeled peptide or protein with a sample comprising a second peptide or protein that interacts, or is suspected of interacting with, the fluorescently-labeled peptide or protein, wherein the interaction yields a complex; and
detecting fluorescence in the complex.

### Claim 7 (depends on 6)

The method of claim 6, wherein the second protein is a fusion protein.

### Claim 8 (depends on 1)

The method of claim 1, wherein the N-terminal cysteine residue of the peptide or protein is produced by protease cleavage.

### Claim 9 (depends on 8)

The method of claim 8, wherein the protease is TEV protease.

### Claim 10 (depends on 6)

The method of claim 6, wherein the detection is performed using FRET or BRET.

### Claim 11

A method for detecting a peptide or protein, comprising
a) contacting a sample comprising an N-terminal cysteine labeled peptide or protein with a cyanobenzothiazole derivative of Formula I
wherein
Z is H, F, Cl, Br, I, CN, amino, alkylamino, dialkylamino, alkyl ester, carboxy, carboxylic acid salt, alkyl amide, phosphate, alkyl phosphonate, sulfate, alkyl sulfonate, nitro, or C1-C10 alkyl optionally unsaturated and optionally substituted with amino, hydroxy, oxo (═O), nitro, thiol, or halo;
each R1 is independently H, F, Cl, Br, I, CN, C1-C6 alkyl, C1-C6 alkoxy, or C1-C6 alkylthio, wherein each alkyl, alkoxy, or alkylthio is optionally substituted with F, Cl, Br, I, amino, alkenyl, alkynyl, cycloalkyl, aryl,alkyl sulfonate, or CO2M wherein M is H, an organic cation, or an inorganic cation;
n is 0, 1, or 2;
Y is a linking group comprising C1-C16 alkyl optionally substituted with one or more halo, oxo (═O), C1-C6alkyl, or C1-C6alkoxy, and optionally interrupted with one or more N(R1), O, S, or —NH—C(═O)— groups; and
X is a fluorescent dye;
so as to yield a fluorescently-labeled peptide or protein; and
b) detecting the presence or absence of fluorescence in the sample.

### Claim 12 (depends on 11)

The method of claim 11, wherein the sample comprises a cell-free translation system.

### Claim 13 (depends on 11)

The method of claim 11, wherein the sample comprises intact eukaryotic cells.

### Claim 14 (depends on 11)

The method of claim 11, wherein the peptide is synthetically derived.

### Claim 15 (depends on 11)

The method of claim 11, wherein the N-terminal cysteine residue of the peptide or protein is produced by protease cleavage.

### Claim 16 (depends on 15)

The method of claim 15, wherein the protease is TEV protease.

### Claim 17 (depends on 11)

The method of claim 11, further comprising:
combining the fluorescently-labeled peptide or protein with a sample comprising a second peptide or protein that interacts, or is suspected of interacting with, the fluorescently-labeled peptide or protein, wherein the interaction yields a complex; and
detecting fluorescence in the complex.

### Claim 18

A method for detecting a peptide or protein, comprising:
a) contacting a sample comprising an N-terminal cysteine labeled peptide or protein with a cyanobenzothiazole derivative of Formula I
wherein
Z is H, F, Cl, Br, I, CN, amino, alkylamino, dialkylamino, alkyl ester, carboxy, carboxylic acid salt, alkyl amide, phosphate, alkyl phosphonate, sulfate, alkyl sulfonate, nitro, or C1-C10 alkyl optionally unsaturated and optionally substituted with amino, hydroxy, oxo (═O), nitro, thiol, or halo;
each R1 is independently H, F, Cl, Br, I, CN, C1-C6 alkyl, C1-C6 alkoxy, or C1-C6 alkylthio, wherein each alkyl, alkoxy, or alkylthio is optionally substituted with F, Cl, Br, I, amino, alkenyl, alkynyl, cycloalkyl, aryl,alkyl sulfonate, or CO2M wherein M is H, an organic cation, or an inorganic cation;
n is 0, 1, or 2;
Y is a linking group comprising C1-C16 alkyl optionally substituted with one or more halo, oxo (═O), C1-C6alkyl, or C1-C6alkoxy, and optionally interrupted with one or more N(R1), O, S, or —NH—C(═O)— groups; and
X is a fluorescent dye;
so as to yield a fluorescently-labeled peptide or protein; and
b) combining the fluorescently-labeled peptide or protein with a sample comprising a second peptide or protein that interacts, or is suspected of interacting with, the fluorescently-labeled peptide or protein, wherein the interaction yields a complex; and
c) detecting fluorescence in the complex.

### Claim 19 (depends on 18)

The method of claim 18, wherein the sample comprises a cell-free translation system.

### Claim 20 (depends on 18)

The method of claim 18, wherein the sample comprises intact eukaryotic cells.

### Claim 21 (depends on 18)

The method of claim 18, wherein the peptide is synthetically derived.

### Claim 22 (depends on 18)

The method of claim 18, wherein the N-terminal cysteine residue of the peptide or protein is produced by protease cleavage.

### Claim 23 (depends on 22)

The method of claim 22, wherein the protease is TEV protease.

### Claim 24 (depends on 18)

The method of claim 18, wherein the detection is performed using FRET or BRET.
